Member

$SYRS will recover. Shorters Will fail

Hopefully management $SYRS is paying attention To the stock price and mobilizes an information update with sound valid data points to highlight and a clear:precise path to next milestone and approval. Emphasizing runway is not enough. They need a strong PR campaign. Highlight investor base i.e Flagship (Moderna). Don’t assume Wall Street knows.

$SYRS great buy at this price. Founder of Moderna is the founder of Flagship. Flagship major investor in Syros. Acquisition???

Moderna and SYRS share Flagship Pioneering as a founding investor. Noubar Afeyan is founder of MRNA and Flagship…agree that SYRS is a natural acquisition target

$SYRS + $MRNA = Acquisition

$SYRS + $MRNA = Acquisition

&SYRS get ready for a Santa Claus rally!

$SYRS is positioning to launch. It’s also an attractive acquisition. Look at the Moderna deal announced yesterday with Pfizer. Modern founder is now head of Flagship. Flagship an investor in $SYRS. Who do think is next to be acquired to beef up Moderna’s oncology division.

Why $SYRS Will be acquired by Moderna

MODERNA AND MERCK ANNOUNCE MRNA-4157/V940, AN INVESTIGATIONAL PERSONALIZED MRNA CANCER VACCINE, IN COMBINATION WITH KEYTRUDA(R) (PEMBROLIZUMAB), MET PRIMARY EFFICACY ENDPOINT IN PHASE 2B KEYNOTE-942 TRIAL

Love this stock. Also bought $SYRS. Read Syros data printout from Dec 10th. 80 plus % response in patients.